Saif Bushnaq, MD
Vascular Neurology · Lubbock, TXNPI 1124435987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Penumbra, Inc. at 43.8% of the total. 2025 is the largest year on record at $2,498, more than ten times the $23 reported in 2020.
Across 124 payments — averaging $47.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Imperative Care, Inc$748
- Stryker$653
- Route 92 Medical, Inc.$642
- Johnson & Johnson$468
- Microvention, Inc.$297
- plus $500 from 6 others
Across 2 payments — averaging $15,900 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$32K
What the payments were for
- Food & beverage$5,890100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 67 | $2,581 |
| Imperative Care, Inc | 16 | $748 |
| Stryker | 11 | $653 |
| Route 92 Medical, Inc. | 1 | $642 |
| Johnson & Johnson | 10 | $468 |
| Microvention, Inc. | 5 | $297 |
| Medtronic | 8 | $266 |
| Novartis | 1 | $117 |
| Qapel Medical Inc | 2 | $55 |
| Argenx US, Inc. | 1 | $26 |
| Livanova USA, Inc. | 1 | $23 |
| Biogen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$532
- AXS VECTA 71$277
- WEB Aneurysm Embolization System$215
- ZOOM 88-T LARGE DISTAL PLATFORM$158
- POD$147
- RED 72$134
- Pipeline$132
- Artemis$125
- AXS INFINITY LS$120
- Penumbra Coil 400$120
- KESIMPTA$117
- Scepter C$115
- STENT$115
- Embotrap$109
- SURPASS EVOLVE$103
- Sofia 6F-125cm STR$100
- Scepter XC$100
How this compares
$5,890 in reported general payments places this provider in the 70th percentile of 76 vascular neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 20 | $8,747 |
| Atorvastatin Calcium | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Lubbock
- Ameer HassanHarlingen$1M
- John VolpiHouston$407K
- Lee BirnbaumSan Antonio$195K
- Amrou SarrajHouston$182K
- Sunil ShethHouston$54K
- Steven WarachAustin$32K
- Jefferson MileyAustin$28K
- Hamidreza SaberAustin$22K
- Haris KamalHouston$21K
- Sean SavitzHouston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.